EcoDrugPlus

Tachykinin Receptor 1

Ensembl ID : ENSOTSG00005041808
Gene Symbol: TACR1
1 Cross references
189 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSOTSG00005034849
Gene Symbol: TACR2
1 Cross references
190 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSOTSG00005019256
Gene Symbol: TACR3
1 Cross references
242 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSOTSG00005003276
Gene Symbol: TACR3L
1 Cross references
242 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSOTSG00005029999
Gene Symbol: TBXAS1
1 Cross references
213 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSOTSG00005044349
Gene Symbol: TBXAS1
1 Cross references
213 Possible Orthologues:

Thromboxane A2 Receptor-Like

Ensembl ID : ENSOTSG00005028394
Gene Symbol: LOC112252014
3 Cross references
186 Possible Orthologues:

Thromboxane A2 Receptor-Like

Ensembl ID : ENSOTSG00005030147
Gene Symbol: LOC112250621
3 Cross references
186 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSOTSG00005012464
Gene Symbol: TYMP
1 Cross references
171 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSOTSG00005009365
Gene Symbol: TYMS
1 Cross references
220 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOTSG00005006049
Gene Symbol: TRHR
1 Cross references
194 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSOTSG00005012490
Gene Symbol: TRHR
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).